Exact Sciences Corporation
EXAS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $851 | $811 | $707 | $713 |
| % Growth | 4.9% | 14.8% | -0.9% | – |
| Cost of Goods Sold | $267 | $249 | $206 | $284 |
| Gross Profit | $584 | $562 | $501 | $429 |
| % Margin | 68.6% | 69.3% | 70.8% | 60.2% |
| R&D Expenses | $117 | $109 | $105 | $100 |
| G&A Expenses | $218 | $209 | $221 | $342 |
| SG&A Expenses | $468 | $456 | $485 | $434 |
| Sales & Mktg Exp. | $250 | $247 | $264 | $91 |
| Other Operating Expenses | $24 | $0 | $6 | $772 |
| Operating Expenses | $609 | $565 | $597 | $1,306 |
| Operating Income | -$26 | -$2 | -$96 | -$876 |
| % Margin | -3% | -0.3% | -13.6% | -122.8% |
| Other Income/Exp. Net | $8 | $2 | -$5 | $0 |
| Pre-Tax Income | -$18 | -$0 | -$101 | -$876 |
| Tax Expense | $2 | $1 | $0 | -$11 |
| Net Income | -$20 | -$1 | -$101 | -$865 |
| % Margin | -2.3% | -0.1% | -14.3% | -121.2% |
| EPS | -0.1 | -0.006 | -0.54 | -4.67 |
| % Growth | -1,487.3% | 98.8% | 88.4% | – |
| EPS Diluted | -0.1 | -0.006 | -0.54 | -4.67 |
| Weighted Avg Shares Out | 189 | 189 | 187 | 185 |
| Weighted Avg Shares Out Dil | 189 | 189 | 187 | 185 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $9 | $8 |
| Depreciation & Amortization | $56 | $55 | $54 | $53 |
| EBITDA | $38 | $53 | -$38 | -$815 |
| % Margin | 4.5% | 6.6% | -5.4% | -114.2% |